Abstract
Intraperitoneal administration of bis(5-amidino-2-benzimidazolyl)methane at well-tolerated daily doses of 25 mg/kg subsequent to challenge and for 3 days thereafter effected over a 1-log reduction in the amount of virus recovered from lungs of cotton rats inoculated intratracheally with respiratory syncytial virus. When animals were immunosuppressed to prolong virus shedding, the reduction in recovered virus achieved with a 7-day dosing schedule of bis(5-amidino-2-benzimidazolyl)methane exceeded 2 logs.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dubovi E. J., Geratz J. D., Shaver S. R., Tidwell R. R. Inhibition of respiratory syncytial virus-host cell interactions by mono- and diamidines. Antimicrob Agents Chemother. 1981 Apr;19(4):649–656. doi: 10.1128/aac.19.4.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubovi E. J., Geratz J. D., Tidwell R. R. Enhancement of respiratory syncytial virus-induced cytopathology by trypsin, thrombin, and plasmin. Infect Immun. 1983 Apr;40(1):351–358. doi: 10.1128/iai.40.1.351-358.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dubovi E. J., Geratz J. D., Tidwell R. R. Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane. Virology. 1980 Jun;103(2):502–509. doi: 10.1016/0042-6822(80)90207-x. [DOI] [PubMed] [Google Scholar]
- Hatch G. E., Slade R., Boykin E., Hu P. C., Miller F. J., Gardner D. E. Correlation of effects of inhaled versus intratracheally injected males on susceptibility to respiratory infection in mice. Am Rev Respir Dis. 1981 Aug;124(2):167–173. doi: 10.1164/arrd.1981.124.2.167. [DOI] [PubMed] [Google Scholar]
- Hruska J. F., Bernstein J. M., Douglas R. G., Jr, Hall C. B. Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother. 1980 May;17(5):770–775. doi: 10.1128/aac.17.5.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hruska J. F., Morrow P. E., Suffin S. C., Douglas R. G., Jr In vivo inhibition of respiratory syncytial virus by ribavirin. Antimicrob Agents Chemother. 1982 Jan;21(1):125–130. doi: 10.1128/aac.21.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson R. A., Prince G. A., Suffin S. C., Horswood R. L., Chanock R. M. Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect Immun. 1982 Jul;37(1):369–373. doi: 10.1128/iai.37.1.369-373.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy T. F., Dubovi E. J., Clyde W. A., Jr The cotton rat as an experimental model of human parainfluenza virus type 3 disease. Exp Lung Res. 1981 May;2(2):97–109. doi: 10.3109/01902148109052306. [DOI] [PubMed] [Google Scholar]
- Taber L. H., Knight V., Gilbert B. E., McClung H. W., Wilson S. Z., Norton H. J., Thurson J. M., Gordon W. H., Atmar R. L., Schlaudt W. R. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics. 1983 Nov;72(5):613–618. [PubMed] [Google Scholar]
- Tidwell R. R., Geratz J. D., Dann O., Volz G., Zeh D., Loewe H. Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. J Med Chem. 1978 Jul;21(7):613–623. doi: 10.1021/jm00205a005. [DOI] [PubMed] [Google Scholar]
- Walsh E. E., Schlesinger J. J., Brandriss M. W. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immun. 1984 Feb;43(2):756–758. doi: 10.1128/iai.43.2.756-758.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson S. Z., Knight V., Wyde P. R., Drake S., Couch R. B. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother. 1980 Apr;17(4):642–648. doi: 10.1128/aac.17.4.642. [DOI] [PMC free article] [PubMed] [Google Scholar]